| 34.51 -2.155 (-5.88%) | 08-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 46.87 |
1-year : | 50.96 |
| Resists | First : | 40.13 |
Second : | 43.63 |
| Pivot price | 38.91 |
|||
| Supports | First : | 34.47 |
Second : | 28.68 |
| MAs | MA(5) : | 38.59 |
MA(20) : | 39.22 |
| MA(100) : | 40.45 |
MA(250) : | 0 | |
| MACD | MACD : | -0.3 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 41.8 |
D(3) : | 62.4 |
| RSI | RSI(14): 37 |
|||
| 52-week | High : | 50.87 | Low : | 32.81 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MDLN ] has closed below the lower bollinger band by 12.3%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ MDLN ] is to continue within current trading range. Bollinger Bands are 6.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 36.54 - 36.74 | 36.74 - 36.9 |
| Low: | 34.01 - 34.25 | 34.25 - 34.45 |
| Close: | 34.15 - 34.51 | 34.51 - 34.82 |
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Wed, 05 Aug 2026
MEDLINE INC. : CITIGROUP CUTS TARGET PRICE TO $45 FROM $55 - Bitget
Wed, 05 Aug 2026
Medline Inc (MDLN) (Q2 2026) Earnings Call Highlights: Strong Growth Amidst Strategic ... - finance.yahoo.com
Wed, 05 Aug 2026
MDLN News Today | Why did Medline stock drop today? - MarketBeat
Wed, 05 Aug 2026
Medline Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MDLN) 2026-08-05 - Seeking Alpha
Wed, 05 Aug 2026
Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings - finance.yahoo.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 846 (M) |
| Shares Float | 357 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 101.4 (%) |
| Shares Short | 29,450 (K) |
| Shares Short P.Month | 27,640 (K) |
| EPS | 1.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.31 |
| Profit Margin | 3.3 % |
| Operating Margin | 5.4 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 6 % |
| Qtrly Rev. Growth | 10.6 % |
| Gross Profit (p.s.) | 8.91 |
| Sales Per Share | 34.46 |
| EBITDA (p.s.) | 3.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,470 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 30.27 |
| PEG Ratio | 0 |
| Price to Book value | 2.59 |
| Price to Sales | 1 |
| Price to Cash Flow | 19.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|